COVID-19 Resources

 

Public Health Agency of Canada COVID-19 virtual library of health data and evidence

Public Health Agency of Canada's COVID-19 mask use advice for community settings has been updated to include the following:

  • Even if masks are not required in an individual’s region or the setting they are in, and whether they are vaccinated or not, wearing a mask is an added layer of protection.
  • Masks are strongly recommended in any crowded setting, including settings with vaccination requirements.
  • Individuals should consider how they could improve the fit of their masks by adjusting features like ties, ear loops, flexible nosepieces, mask fitters or braces. Choosing a mask with ties or bands that go around the back of the head may help provide a better fit.
  • While non-medical masks help prevent the spread of COVID-19, medical masks and respirators provide better protection. A medical mask is recommended for some groups and settings, including:
    • anyone who has tested positive or has symptoms of COVID-19;
    • people caring for someone who has tested positive or has symptoms of COVID-19,
    • people living in overcrowded settings with someone who has tested positive or has symptoms of COVID-19;
    • people who are at risk of more severe disease or outcomes from COVID-19; and
    • people who are at a higher risk of exposure to COVID-19 because of their living situation.

     

      COVID-19: Epidemiology, virology, and prevention: UpToDate Coronavirus Topic

      COVID-19 signs, symptoms and severity of disease: A clinician guide

      Coronavirus disease (COVID-19): For health professionals 

      CSHP's COVID-19 Patient Discharge Tips   

     

    General
    Vaccine storage, handling, and rollout
    Vaccine Induced Immune Thrombotic Thrombocytopenia (VITT)
    Adverse effects
    National Advisory Committee on Immunization (NACI) Recommendations
    Guidelines

    Drug tables

    Critical care and medical emergencies

    COVID-19 Pharmacy Specialty Network
    In an effort to share information and best hospital pharmacy practices regarding COVID-19, the Canadian Society of Hospital Pharmacists has set-up a special open access (free to members and non-members) Pharmacy Specialty Network (PSN). Join the COVID-19 PSN here.

    International Networking Resources

    ASHP COVID-19 Connect Community: American Society of Health-System Pharmacists


    Also on this page


    See  CSHP's full statement on COVID-19 here.

    Excerpt:

    Care for patients is at the heart of the hospital pharmacy profession. During the pandemic, you put yourself at even higher risk than you normally experience in the course of your work. We acknowledge the dedication and professionalism that underscores your service to public health. We also see your humanity and the vulnerability inherent in that service and are here to support you through this journey.
    ~Tania Mysak, BSP, PharmD, CSHP President; Jody Ciufo, MBA, CSHP CEO

    Additional Member Updates


     

        

       

       
      COVID-19: Coping and Resilience for Pharmacy Professionals
       
      06/29/2021 11:00
      Novel Coronavirus: COVID-19 vaccines
       
      01/28/2021 00:00
      PM and PSWs: The Ottawa Hospital experience with the Pfizer COVID-19 vaccine
      01/26/2021 00:00
      COVID–19 treatment updates
      Slides  
      09/02/2020 00:00
      COVID–19 in the US: the perspective of pharmacists on policy and practice
       
      08/26/2020 00:00
      Preparing for a Second COVID Wave: Personal and Departmental Considerations
      Slides  
      06/30/2020 00:00
      Disease in the Body of COVID-19 Related Scientific Literature: Fabrication, Falsification or Fallacy
      Slides  
      06/20/2020 00:00
      Drug Shortages During the COVID-19 Pandemic: Conservation Strategies and Therapeutic Alternatives
      Slides   
      06/18/2020 00:00
      Pharmacy Student Experiences During COVID-19 Pandemic
       
      06/09/2020 00:00
      Care of Older Adults During the COVID-19 Pandemic: Reflections and Strategies for Medication and Patient Safety
      Slides  
      06/04/2020 00:00
      Remdesivir — What's with all the noise?
      Slides  
      06/02/2020 00:00
      Our Experience with Virtual Care – Perspectives from the Pharmacists Clinic
      Slides  
      05/26/2020 00:00
      Pharmacy Involvement at a Long-Term Care Home
      Slides  
      05/23/2020 00:00
      Medications at the End-of-Life: Palliative Care Pharmacotherapy for the Dying Patient - Part 2
      Slides  
      05/21/2020 00:00
      Medications at the End-of-Life: Palliative Care Pharmacotherapy for the Dying Patient - Part 1
      05/19/2020 00:00
      The Role of Team-Based Primary-Care Pharmacists During a Pandemic
      Slides  
      05/14/2020 00:00
      Panel: Pharmacy Residents' Experiences During a Pandemic
        
      05/12/2020 00:00
      Prescribing the Right Course of Action: Pharmacy Ethics in a Pandemic
      Slides  
      05/07/2020 00:00
      COVID-19: What Employees Need from Leadership
      Slides  
      05/05/2020 00:00
      Field Hospitals: A Royal Canadian Medical Service Perspective
      Slides  
      04/30/2020 00:00
      Ventilators are only good if you have the medications to use them: understanding drug supply during COVID-19
      Slides   
      04/23/2020 00:00
      Conserving Drugs with Sterile Compounding During the COVID-19 Pandemic
      Slides  
      04/21/2020 00:00
      Pediatric COVID-19 Treatment Considerations
      Slides  
      04/16/2020 00:00
      ICU 101 for Pharmacists - Crash Course in Critical Care — Part 2
      Slides  
      04/14/2020 00:00
      ICU 101 for Pharmacists - Crash Course in Critical Care — Part 1
      Slides  
      04/09/2020 00:00
      What are the Treatment Options for COVID-19? (Panel Discussion)
       
      04/09/2020 00:00
      Adapting Hospital Pharmacy Practice During a Pandemic
      Slides  
      04/07/2020 00:00
      Evaluating Evidence for Emerging Therapies During a Pandemic
      Slides  
      04/02/2020 00:00
      COVID19: Managing Autoimmune, Psychiatric and Trauma Responses
      Slides  
      03/31/2020 00:00
      Implementing Hospital Telepharmacy: Review of CSHP’s Telepharmacy Guidelines
      Slides  
      03/26/2020 00:00
      Going Nsane over NSAIDs: Evaluation of the evidence behind the rejection of ibuprofen in management of COVID-19
      Slides  
      03/24/2020 00:00
       

       

       

      Canadian Journal of Hospital Pharmacy 

      Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?

       

      CSHP-BC COVID-19 What Pharmacists Know Now: Free Short Video Series

      COVID-19: What Pharmacists Know Now: Coagulopathy in COVID-19

      Presented by Celia Culley
      BSP, ACPR, PharmD

      View Recording

      (20 minutes)

      May 5, 2020
      COVID-19 and Cancer Patients

       

      Presented by Sally Waigenein BSc(Pharm), PharmD, ACPR

      View recording

      (15 minutes)

      April 20, 2020

      I am Pregnant or Breastfeeding – What Should I do?

      Presented by Hilary Rowe BSc(Pharm), PharmD, ACPR

       View recording   (18 minutes)

      April 14, 2020
      Injecting Knowledge – a COVID-19 Vaccine Update
       
      Presented by Jillian Reardon, BSc(Pharm), PharmD, ACPR

      View recording  (14 minutes)

      April 6, 2020
      Role of Statins 
       
      Presented by Ricky Turgeon, BSc(Pharm), ACPR, PharmD

      View recording  (14 minutes)

      April 3, 2020
      COVID-19 Virus Stability and Transmission
       
      Presented by Kelly Grindrod, BScPh(arm), PharmD, MSc

      View recording 
      (18 minutes)

      March 30, 2020
      Should we avoid corticosteroids? Presented by Megan Harbin, BSc(Pharm), PharmD, ACPR

       View recording

      (22 minutes)

      March 27, 2020

      Role of Hydroxychloroquine
       

      Presented by Gregory Mah, PharmD

       View recording

      (19 minutes)

      March 27, 2020
      Should patients discontinue their ACE inhibitors and ARBs? Presented by Arden Berry, BSc, BSc(Pharm), PharmD, ACPR

       View recording

      (9 minutes)

      March 25, 2020
      Does ibuprofen worsen COVID-19 Infection? Presented by Doson Chua, BSc(Pharm), PharmD, FCSHP,  BCPS, BCCP

       View recording

      (5 minutes)

      March 24, 2020

       


       

       

      CSHP in the News

      CMAJ  Temporary fixes to chronic drug shortages leave Canada vulnerable

      CBC Second Opinion - Safety Prioritized

      CBC-Metro Morning - Implications for workers left off of Ontario's "pandemic pay" 

      Winnipeg Free Press - Drug shortages push federal government to seek new suppliers  

      CTV News - COVID-19 exposes drug supply gaps as 'made in Canada' solution proposed

      CTV News - Forgotten Healthcare Workers Not on list for Ontario's $4 per hour wage increase 

      Globe and Mail — Doctors brace for shortages of sedation drugs needed for surgeries, intubation   

      Article archive

       

      Media Contact

      Christina Cella 
      613-912-3494

       

       

      We have partnered with all major pharmacy sector stakeholders to advocate on a number of fronts with several government agencies. In addition to contributing to pandemic response teams at various levels, CSHP signed on to an open letter to the Government of Canada  , led by CPhA and co-signed by 16 other national and provincial organizations, that calls for Health Canada to recognize pharmacists as essential healthcare providers, with respect to the supply and allocation of PPE. CSHP is working with CPhA to craft evidence-based PPE best-practice recommendations.

       

       

      CSHP members – pharmacists, pharmacy technicians, pharmacy students, interns and residents – insured with our preferred provider BMS are in good hands. Please review the COVID-19: Insurance Coverage Position Statement   for details. A note for our retired members: If you return to work, you must purchase an active policy (and should check with your provincial regulatory body about registration to active status). Pro-rated fees are available for shorter terms between now and June 30, 2020. Learn more here .

       

       

      A complete .pdf copy of CSHP member, Dr. Joel Lamoure's letter can be accessed here  .

      Excerpt:

      In a period of personal and professional uncertainty, and a seemingly endless wave of scary recent information, I wish to add a few thoughts and validations for my colleagues. I am speaking from 30 years of pharmacy including neurosurgical ICU, psychiatry practice and serving as the UNESCO Canadian Section Chief for medical bioethics. The number one paper that people accessed from my publications around the world this week was about Management of Panic Disorder, so I think it is time for me to weigh in. 
      ~Joel Lamoure RPh., DD., FASCP

       

       

      Social Media

      Use  #COVID19RX for treatments related to COVID-19

       

      Ethics